PLpro Inhibitors as a Potential Treatment for COVID-19
The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent coronavirus disease 2019 (COVID-19) pandemic have posed a serious threat to human health and society [...]
Saved in:
| Main Authors: | Yu Han, Feng Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/6/1417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
by: Stefanie M. Bader, et al.
Published: (2025-04-01) -
COVID-19 Prevention and Treatment—2nd Edition
by: Silvia De Francia, et al.
Published: (2024-09-01) -
Structure-Based Design and In-Silico Evaluation of Computationally Proposed Curcumin Derivatives as Potential Inhibitors of the Coronaviral PLpro Enzymes
by: Hakan Alici
Published: (2025-05-01) -
Editorial: Safety and Effectiveness of COVID-19 Vaccines on COVID-19 Infection and Its Long-Term Consequences
by: Ana Paula Junqueira-Kipnis
Published: (2025-01-01) -
Virology Applications to the COVID-19 Pandemic
by: Evangelia Georgia Kostaki
Published: (2025-02-01)